INTRODUCTION
It was initially demonstrated in 1955 (1) (2) (3) (4) and human (1, 5) erythrocytes can synthesize the glutathione. However, these attempts to demonstrate de novo synthesis of GSH by measuring glycine incorporation into GSH using erythrocytes or hemolysates were hampered by technical difficulties. Snoke and Bloch (6-8) demonstrated in yeast and in pigeon liver that GSH is synthesized by two enzymes which catalyze the following reactions: Mg++ These authors also demonstrated that GSH synthetase catalyzes an exchange reaction between glycine and preformed GSH (8) . Thus, the demonstration of glycine incorporation into GSH using either intact erythrocytes or hemolysates could reflect either de novo synthesis or the exchange reaction. More recently, Sass (9) and Jackson (10) have demonstrated that de novo glutathione synthesis occurs in human erythrocytes.
We are now reporting the characterization of the two enzymes of GSH synthesis in erythrocytes. We have developed reproducible and relatively simple assays for these enzymes. Using these assays we have defined the normal levels of these enzymes in erythrocytes and have recently reported a family deficient in the enzyme GSH synthetase (11, 12) . In a subsequent paper we shall report the purification and properties of these two enzymes from human erythrocytes." METHODS Preparation of erythrocyte extracts. Erythrocytes were isolated from 5-ml samples of blood collected in EDTA by centrifugation in a clinical centrifuge in conical, graduated glass tubes. The volume of packed erythrocytes was estimated after the cells were washed two times in isotonic saline. 10 volumes of cold distilled water were then added to the erythrocyte pellet and, after mixing, samples were taken directly for enzyme assay. In some experiments initial centrifugation to remove stroma was performed. These experiments demonstrated that all of the GSH synthetic activity was contained in the supernatant fraction. In most experiments this centrifugation step was omitted since the presence of stroma in reaction mixtures did not influence the results.
In other experiments leukocytes (13) and platelets (14) were isolated, and, after the pellets were diluted in distilled water, they were assayed for GSH and 'y-glutamyl cysteine (GC) synthetase activity. These experiments indicated that less than 1% of the enzyme activity measured in the erythrocyte preparations could be due to the contaminating leukocytes and platelets.
Enzyme assays. Assay of both y-glutamyl cysteine (GC) synthetase and GSH synthetase depends on the precipitation of the reaction products from incubation mixtures as cadmium mercaptides. Since these mercaptides are insoluble at neutral pH but are soluble in acid, the precipitates can be washed free of radioactive substrates with water and then dissolved in acid and counted. In preliminary experiments it was found that the use of Falcon disposable plastic tubes (75 X 12 mm) greatly facilitated the handling and recovery of these precipitates (Falcon Plastics, Division of B-D Laboratories, Inc., Los Angeles, Calif.). When and enzyme in a volume of 0.346 ml. Reactions were started with the addition of glutamic acid and were incubated 1 hr at 37'C. The pH of the reaction mixtures was 7.5 since cysteine was added as its hydrochloride. Reactions were stopped by the addition of 0.03 ml of 60%o trichloroacetic acid. The remainder of the assay procedure was identical to that used to measure GSH synthetase. When hemolysates were assayed, 0.5-3.0 mg of hemoglobin (Hb) were contained in the reaction mixtures. Blank values were determined as described above for GSH synthetase.
Reaction products. The product of the GC synthetase reaction was shown to be L-'y-glutamyl cysteine. A large-scale incubation (10 times the standard assay) was carried out to accumulate the reaction product of the GC synthetase reaction. In this and in the GSH synthetase reaction described below dithiothreitol was omitted from the reaction mixture to prevent any possible formation of mixed disulfides with this compound in the subsequent oxidation step. After the reaction was stopped, the TCA was extracted from the incubation mixture with ether. The pH was then adjusted to 9.0 with NaOH and air was bubbled through the solution until all of the sulfhydryl groups of the reaction mixture were oxidized. The pH of the reaction mixture was then adjusted to 2.2 and the reaction mixture was poured onto a 1.5 X 25 cm column of Bio-Rad AG 50 X 8 (200-400 mesh) Bio-Rad Laboratories, Richmond, Calif. cation exchange resin previously equilibrated with 0.032 Mi pyridine acetate, pH 2.92. In previous experiments it was shown that glutamic acid, glycine, cysteine, GSH, and GC were eluted from this column using 0.032 M pyridine acetate, pH 2.92, while oxidized GSH, GC, and cysteine were retained on the column and could subsequently be eluted with 0.1 M pyridine acetate, pH 3.1. Thus, glutamic acid-3H was separated from the radioactive product of GC synthetase. Fractions containing the radioactive product eluted with 0.1 M pyridine acetate were pooled, lyophilized, and redissolved in H20. Aliquots of this product were then analyzed on the standard long column for protein hydrolysates of a Beckman 120C automatic amino acid analyzer (Fig. 1) . The column eluate was assayed tor radioactivity and ninhydrin reactivity. Oxidized, chemically synthesized -y-glutamyl cysteine was eluted as a distinct peak between serine and glutamic acid.
The product of the GSH synthetase reaction was shown to be GSH in a similar manner. A large-scale GSH synthetase incubation and subsequent air oxidation of the reaction product was followed by chromatography on the AG 50 column described above. The radioactive reaction product was completely separated from the substrate glycine--"C. This reaction product was then chromatographed on the amino acid analyzer (Fig. 1) . Authentic glutathione disulfide (GSSG) is eluted between aspartic acid and threonine. Aliquots of the reaction product were also oxidized with performic acid (17) and then hydrolyzed for 22 hr in constant boiling HCl in sealed evacuated tubes (18) .
Materials. Glycine-J'C and L-glutamic acid-3H were purchased from New England Nuclear Corp., Boston, Mass.; t-Boc-L-glutamic acid--y-benzyl ester and L-cystine dimethyl ester 2HCl were purchased from Fox Chemical Co., Los Angeles, Calif.
Synthesis of L-y-glutamyl cysteine. L-cystine dimethyl ester (2.95 mmoles) and t-Boc-L-glutamic acid-,y-benzyl ester (5.9 mmoles) were dissolved in 20 ml of dichloromethane. N-ethynylmethyldiethylamine (19) (5.9 mmoles dissolved in 5 ml dichloromethane) was added slowly and the mixture was stirred for 2 hr at room temperature. The reaction mixture was then filtered and the filtrate was washed with 0.5 M citric acid, H20, and saturated sodium bicarbonate. The reaction mixture was dried over sodium sulfate, filtered, and evaporated to dryness; the product was then recrystallized from ethyl acetate using petroleum ether. The product was then dissolved in 40 ml trifluoroacetic acid and HBr was bubbled through the mixture for 30 min to remove the t-Boc and benzyl ester groups. The product was precipitated by the addition of ether and then saponified in 1 M sodium hydroxide: dioxane:: 1: 6 for 2 hr at room temperature. The solution was neutralized with HCl and the product was precipitated by the addition of ethanol. The final product was examined by amino acid analysis and nuclear magnetic resonance spectroscopy and the results of these studies were consistent with the structure of L-ly-glutamyl cystine. Alternatively, L--y-glutamyl cystine was purchased from Cyclo Chemical Corp., Los Angeles, Calif. Either of these preparations served equally well as substrate for GSH synthetase. 'y-Glutamyl cystine was reduced to 'y-glutamyl cysteine by dissolving 0.1-0.5 g of 'y-glutamyl cystine in 2.0 ml of 0.2 M Tris HCl, pH 9.0. The solution was then cooled to 4°C and 5.0 ml of 1.5 M potassium borohydride was added. After incubation for 15 min at 37°C, the solution was cooled and acidified to pH 4 with 4 M HCl. After centrifugation to remove the precipitated potassium borate, the 'y-glutamyl cysteine content of the solution was assayed using 5,5'-dithiobis-2-nitrobenzoic acid (DTNB) (20) .
RESULTS
The enzymes of glutathione synthesis can be measured in crude hemolysates and the properties of these enzymes are given below. We have also purified these enzymes extensively and studies of the purified enzymes are given in the subsequent report.'
Glutamyl cysteine synthetase. GC synthetase was assayed as described in Methods. The reaction was linear with time for at least 1 hr and was also linear with respect to the amount of hemolysate added, up to 3.0 mg hemoglobin. The requirements for this reaction are C".s-5-Cys 0.1 TIME (MIN) FIGURE 1 Chromatography of reaction products on a Beckman 120C automatic amino acid analyzer. The stippled curves represent the chromatogram of the isolated, oxidized product of GC synthetase. Both the peaks corresponding to oxidized GC and the mixed disulfide of GC and cysteine were radioactive. The striated curve represents the chromatogram of the isolated oxidized product of GSH synthetase which corresponds to authentic GSSG. The chromatogram of the performic acidoxidized, acid-hydrolyzed product of GSH synthetase is shown in the solid curve. In this experiment 1.3 ,umoles cysteic acid, 1.2 /Amoles glutamic acid, and 1.1 /Amoles glycine were eluted. (Table II) .
The oxidized product of GSH synthetase was isolated as described in Methods and was then analyzed by chromatography on the amino acid analyzer as shown in Fig. 1 . This compound was eluted in the position of authentic GSSG. Further evidence that the product was GSSG was obtained by demonstrating that the reaction product served as a substrate for glutathione reductase. Amino acid analysis of the performic acid-oxidized and acid-hydrolyzed reaction product disclosed equimolar amounts of glycine, glutamic acid, and cysteic acid (also shown in Fig. 1 ).
Glutathione synthesis in erythrocytes from normal subjects. The enzymes of GSH synthesis were measured in hemolysates from 25 FIGURE 2 Effect of cell age on the enzymes of GSH synthesis. Blood samples from patients with acquired hemolytic anemia and from normal subjects were fractionated into "reticulocyte-rich" and "reticulocyte-poor" fractions by differential centrifugation. Hemolysates of these fractions and of the unfractionated erythrocytes were assayed for GC synthetase (@) and GSH synthetase (0) activity. The lines are plotted by the method of least mean squares.
Dimant et al. (1) have shown that erythrocyte GSH turns over with a ti of 4 days, while GSH synthetase -could potentially regenerate i of the erythrocyte GSH in 40 min. 2 In order to evaluate the effect of cell age on the enzymes of GSH synthesis, samples of blood from patients with acquired hemolytic anemias and normal subjects were fractionated into reticulocyte-rich and reticulocytepoor fractions by differential centrifugation. Enzyme levels were compared to reticulocyte count as shown in Fig. 2 . There is no effect of reticulocyte count on GSH synthetase levels, while GC synthetase levels are slightly higher in reticulocyte-rich blood. The correlation of GC synthetase with reticulocyte count is of borderline statistical significance, however (t = 2.0, when t = 2.05 P < 0.05). When enzyme levels were measured in a patient with pyruvate kinase deficiency (not shown in Fig. 1 ) with 80% reticulocytes, GC synthetase activity was 0.46 /mole GC formed per g Hb per min, while GSH synthetase activity was 0.17 /Amole GSH formed per g Hb per min, further suggesting that the levels of these enzymes are not strongly dependent on cell age. It is of interest that GC synthetase is more unstable in vitro1 than GSH synthetase, which is in agreement with this in vivo data.
Glutathione synthetase deficiency. We have reported a patient with GSH synthetase deficiency (12, 13) who has a compensated hemolytic disorder with erythrocyte 2Assuming an erythrocyte GSH level of 15 /Amoles/g hemoglobin.
GSH levels 10-20% of normal. The levels of GC synthetase in the patient and his family were normal. We have now measured GSH synthetase in the relatives of this patient. The GSH synthetase levels, shown in Fig. 3 sate was unable to catalyze the synthesis of GSH from either the constituent amino acids or from GC and glycine as shown in Table III . Homogeneous GSH synthetase was added to the patient's hemolysate to exclude the possibility that this defect was due to an inhibitor of GSH synthetase. GSH synthetase corrected the inability of the hemolysate to catalyze the synthesis of GSH from GC. Added glutamic acid and cysteine replaced the requirement for GC, indicating that GC synthetase was present in the hemolysate. Since the patient's erythrocytes contained some GSH as measured with DTNB, we next examined the possibility that the sulfhydryl compound in the patient's erythrocytes was GC rather than GSH. In these experiments the mercaptan was isolated from the patient's cells as described in Methods. After air oxidation this compound was tested as a substrate for glutathione reductase. These experiments indicated that the sulfhydryl compound in the patient's erythrocytes is not GC, since it serves as a substrate for glutathione reductase. Oxidized GC is inactive as a substrate for glutathione reductase. This experiment does not exclude the presence of low levels of GC in the patient's erythrocytes. Since the patient's erythrocytes contain low levels of GSH, his immature erythrocytes must have the capacity to synthesize GSH. Either the mutant enzyme is unstable and is thus absent in circulating erythrocytes, or it is destroyed in the preparation of hemolysates for assay. This latter alternative is somewhat unlikely, since the patient's erythrocytes failed to incorporate significant amounts of glycine-"C into GSH when fresh, intact cells were incubated with glycine-14C (21) .
DISCUSSION
Much of the previous uncertainty about the ability of erythrocytes to synthesize GSH de novo has derived from the fact that experiments were carried out using intact cells or hemolysates which contained large amounts of GSH. Failure to measure the enzymes of GSH synthesis directly led to uncertain interpretation of radioactive incorporation data. Recently Sass (9) showed an increment in total GSH in hemolysates after incubation with glycine, glutamic acid, cysteine, and ATP, indicating some de novo synthesis of GSH. We have demonstrated and quantitated the levels of GSH synthesizing enzymes in hemolysates. Furthermore, we have described assays for each of the enzymes and have demonstrated that exchange of glycine into preformed GSH is not a problem using this technique. When glycine incorporation into GSH is measured using intact cells, some exchange probably occurs (Table II) , although the bulk of the incorporation reflects de novo synthesis. Jackson (10) has reported GSH synthetase levels 5-fold higher than those reported here. The assay used by this author is indirect and does not distinguish between the substrate GC and the product GSH. Since the substrate concentration used was 200-fold greater than the GSH product formed, it may be difficult to measure accurately product formation in the presence of large amounts of GC using this technique.
Several patients with presumed GSH synthetase deficiency have been described previously, although heterozygotes were not detected in these studies since direct enzyme assays were not used (22, 23) . The level of GSH in heterozygotes is normal, so that they can be detected only by measuring GSH synthetase directly. The frequency of GSH synthetase deficiency is unknown, although it must be rare. Whether heterozygotes are susceptible to drug-induced hemolysis remains to be determined. In the future it should be possible to screen patients with Heinz body anemias for deficiency of the enzymes of GSH synthesis, since the assays are not difficult and the substrates are commercially available.
The physiological role of GSH synthesis in red cell metabolism remains to be elucidated. The relatively great capacity for GSH synthesis suggests that this pathway may be important in protecting cells against oxidative stress. This may be especially true in patients with deficiency of one of the other enzymes of the oxidative pathway. Thus, Srivastava and Beutler (24) demonstrated that erythrocytes are permeable to oxidized glutathione. When the capacity to reduce GSSG is impaired, cells may lose their glutathione. In this situation de novo GSH synthesis may be important in restoring cellular levels of GSH. Jacob and Jandl (25) demonstrated that, after 90% of intracellular GSH was alkylated in vitro with N-ethylmaleimide, erythrocytes survived normally when transfused back to the donors. This may be explained by the fact that GSH synthesis could restore normal levels of GSH in these cells within 1 hr, assuming that one can extrapolate in vitro enzyme activity to the in vivo situation. Under normal circumstances this pathway functions at a low level relative to its capacity and the cellular GSH level remains constant. The mechanism by which the pathway is regulated to maintain GSH levels is unknown.
